{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:08:20Z","timestamp":1777558100703,"version":"3.51.4"},"reference-count":10,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T00:00:00Z","timestamp":1453420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Diabetes and Vascular Disease Research"],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:p>At the time of this study, guidelines recommended a primary goal of low-density lipoprotein cholesterol level less than 100\u2009mg\/dL for all patients, an optional goal of low-density lipoprotein cholesterol less than 70\u2009mg\/dL for patients with overt cardiovascular disease and statins for patients with diabetes and overt cardiovascular disease and patients 40\u2009years and older with diabetes and at least one risk factor for cardiovascular disease. This study examined statin use and achievement of lipid goals among 111,730 Medicare fee-for-service beneficiaries 65\u2009years and older in 2011. Three-quarters of patients met the low-density lipoprotein cholesterol goal of less than 100\u2009mg\/dL. Patients with cardiovascular disease were more likely to meet the goal than those without, not controlling for other differences. Patients on a statin were more likely to meet the goal. There is considerable opportunity for improvement in cholesterol management in high-risk patients with diabetes mellitus.<\/jats:p>","DOI":"10.1177\/1479164115620980","type":"journal-article","created":{"date-parts":[[2016,1,23]],"date-time":"2016-01-23T20:08:18Z","timestamp":1453579698000},"page":"244-246","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Low-density lipoprotein cholesterol level and statin use among Medicare beneficiaries with diabetes mellitus"],"prefix":"10.1177","volume":"13","author":[{"given":"Laura G","family":"Qualls","sequence":"first","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley G","family":"Hammill","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew L","family":"Maciejewski","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University School of Medicine, Durham, NC, USA"},{"name":"Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley H","family":"Curtis","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC, USA"},{"name":"Department of Medicine, Duke University School of Medicine, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W Schuyler","family":"Jones","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC, USA"},{"name":"Department of Medicine, Duke University School of Medicine, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2016,1,22]]},"reference":[{"key":"bibr1-1479164115620980","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8651(03)00080-8"},{"key":"bibr2-1479164115620980","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc11-S011","volume":"34","author":"Standards of medical care in diabetes\u20132011","year":"2011","journal-title":"Diabetes Care"},{"key":"bibr3-1479164115620980","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000420"},{"key":"bibr4-1479164115620980","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1213829"},{"key":"bibr5-1479164115620980","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115270"},{"key":"bibr6-1479164115620980","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.5.499"},{"key":"bibr7-1479164115620980","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.304477"},{"key":"bibr8-1479164115620980","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67394-1"},{"issue":"25","key":"bibr9-1479164115620980","first-page":"2889","volume":"63","author":"Stone NJ","year":"2014","journal-title":"Circulation"},{"key":"bibr10-1479164115620980","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0126"}],"container-title":["Diabetes and Vascular Disease Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1479164115620980","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1479164115620980","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1479164115620980","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:20:55Z","timestamp":1777400455000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1479164115620980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,22]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1177\/1479164115620980"],"URL":"https:\/\/doi.org\/10.1177\/1479164115620980","relation":{},"ISSN":["1479-1641","1752-8984"],"issn-type":[{"value":"1479-1641","type":"print"},{"value":"1752-8984","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,22]]}}}